Dunér Pontus, Al-Amily Israa Mohammad, Soni Arvind, Asplund Olof, Safi Fateme, Storm Petter, Groop Leif, Amisten Stefan, Salehi Albert
Department of Clinical Science (P.D.), Skånes Universitetssjukhus, Division of Experimental Cardiovascular Research; Islet Cell Physiology (I.M.A.-A., A.So., O.A., F.S., P.S., S.A., A.Sa.); Diabetes and Endocrinology (L.G.); University of Lund, 205 02 Sweden; and Department of Neuroscience and Physiology (A.Sa.), Metabolic Research Unit, University of Goteborg, 405 30 Goteborg, Sweden.
J Clin Endocrinol Metab. 2016 Dec;101(12):4637-4645. doi: 10.1210/jc.2016-1884. Epub 2016 Sep 16.
Adhesion G protein-coupled receptor (GPCR)-G1 (ADGRG1) is the most abundant GPCR in human pancreatic islets, but its role in islet function is unclear.
Investigate how ADGRG1 expression and activation by its ligand, collagen III, impacts β-cell function in normal and type 2 diabetic (T2D) islets.
Genes associated with the ADGRG1 in human islets was probed by RNA-sequencing of human pancreatic islet isolated from cadaveric donors, followed by functional studies on β-cell proliferation, apoptosis, and insulin secretion in human and mouse islets and in INS-1 cells.
Changes in β-cell gene expression, proliferation, apoptosis, and insulin secretion were quantified by RNA-sequencing, qPCR, Thymidine incorporation, Western blotting, and RIA, respectively.
ADGRG1 is the most abundant GPCR mRNA in both human and mouse islets, and its expression in human islets strongly correlates with genes important for β-cell function and T2D risk. The expression of ADGRG1 was reduced in islets of T2D donors, in db/db mouse islets, and in isolated human islets exposed to chronic hyperglycemia. Beneficial effects of collagen type III on β-cell function via activation of the cAMP/protein kinase A pathway, suppression of RhoA and caspase-3 activity, increased β-cell viability, and proliferation were abolished when ADGRG1 was down-regulated in β-cells.
We demonstrate a mechanistic link between ADGRG1 expression and β-cell function. Pharmacological agents that promote expression or activation of the ADGRG1 receptor may represent a novel approach for the treatment of T2D.
黏附G蛋白偶联受体(GPCR)-G1(ADGRG1)是人类胰岛中含量最丰富的GPCR,但其在胰岛功能中的作用尚不清楚。
研究ADGRG1的表达及其配体Ⅲ型胶原蛋白的激活如何影响正常和2型糖尿病(T2D)胰岛的β细胞功能。
通过对从尸体供体分离的人类胰岛进行RNA测序,探究人类胰岛中与ADGRG1相关的基因,随后对人类和小鼠胰岛以及INS-1细胞中的β细胞增殖、凋亡和胰岛素分泌进行功能研究。
分别通过RNA测序、qPCR、胸苷掺入、蛋白质免疫印迹和放射免疫分析对β细胞基因表达、增殖、凋亡和胰岛素分泌的变化进行定量分析。
ADGRG1是人类和小鼠胰岛中含量最丰富的GPCR mRNA,其在人类胰岛中的表达与对β细胞功能和T2D风险重要的基因密切相关。T2D供体的胰岛、db/db小鼠胰岛以及暴露于慢性高血糖的分离人类胰岛中ADGRG1的表达均降低。当β细胞中ADGRG1表达下调时,Ⅲ型胶原蛋白通过激活cAMP/蛋白激酶A途径、抑制RhoA和半胱天冬酶-3活性、增加β细胞活力和增殖对β细胞功能的有益作用被消除。
我们证明了ADGRG1表达与β细胞功能之间的机制联系。促进ADGRG1受体表达或激活的药物可能代表一种治疗T2D的新方法。